Lexology September 12, 2025
On September 9, 2025, the U.S. Food and Drug Administration (FDA) announced it is launching a targeted initiative to combat deceptive drug advertising. According to the announcement, the FDA sent thousands of letters warning pharmaceutical companies to remove alleged misleading ads, in addition to issuing approximately 100 cease-and-desist letters to companies with alleged deceptive ads. This initiative will also involve rulemaking to address the “adequate provision” loophole that the FDA believes has enabled some companies to exploit digital platforms without full risk...
Today's Sponsors
Today's Sponsor